Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

OBJECTIVE: To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant, versus warfarin and other alternatives for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation (AF). METHODS: A Markov model estimated the cost-effectiveness of dabigatra...

Full description

Saved in:
Bibliographic Details
Main Authors: Kansal, Anuraag R, Sorensen, Sonja V, Gani, Ray, Robinson, Paul, Pan, Feng, Plumb, Jonathan M, Cowie, Martin R
Format: Artigo
Language:Inglês
Published: BMJ Group 2012
Subjects:
Heart Rhythm Disorders
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3308473/
https://ncbi.nlm.nih.gov/pubmed/22422743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2011-300646
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items